Table 3.
Reference | Year | Number of cases | Total prevalence | Length of Barrett’s epithelium | |||
---|---|---|---|---|---|---|---|
0-4 mm | 5-9 mm | 10-29 mm | ≥30 mm | ||||
26 | 2000 | 650 | 15.7% | 15.1% | 0.6% | ||
27 | 2003 | 548 | 12.2% | * | 12.0% | 0.2% | |
28 | 2005 | 2,577 | 20.8% | 17.5% | 3.1% | 0.2% | |
29 | 2008 | 5,338 | 37.6% | 37.4% | 0.2% | ||
30 | 2008 | 6,504 | 10.3% | 9.4% | 1.7% | 0.5% | |
31 | 2009 | 869 | 43.0% | ||||
32 | 2012 | 832 | 22.1% | 22.1% | 0% | ||
33 | 2013 | 18,792 | 7.9% | ||||
34 | 2016 | 3,788 | 5.2% | * | * | 5.2% | 0.03% |
Present study | 2020 | 3,353 | 56.2% | * | 30.0% | 26.2% | 0.03% |
*Cases with this length were not considered to be positive for Barrett’s epithelium.